Stay updated on Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision stamp in the page footer has been updated to v3.6.5, indicating a newer build of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe footer now displays Revision: v3.6.4, replacing v3.6.3, indicating a new release of the site interface.SummaryDifference0.0%

- Check51 days agoChange DetectedStudy Record History now shows a new release entry: Revision: v3.6.3, and the preceding Revision: v3.6.2 entry has been removed. This updates the revision log to reflect the latest platform update.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a new software release has been deployed for the page.SummaryDifference0.0%

- Check73 days agoChange DetectedThe history now shows recruitment is closed, with the note that no longer looking for participants. The version in the history updates to Revision: v3.6.0, replacing the prior Revision: v3.5.5.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision label changed from v3.5.4 to v3.5.5 in the page header, signaling a newer build/version reference. It represents a metadata update rather than a modification to study content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.